VitalityMDs has been offering semaglutide since 2022 with great success and now adds tirzepatide for even better results. This new weight loss tool – Zepbound™ (tirzepatide) – was recently approved by the U.S. Food and Drug Administration as the only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors.

This once weekly injection is used to lose and keep weight off for overweight or obese adults and should be used with a reduced-calorie diet and increased physical activity. In a recent published trial, tirzepatide resulted in a weight loss of 17.8% of body weight compared with 12.4% for semaglutide.

To determine which weight loss tool is right for you, schedule an appointment with board-certified health and wellness coach Dalia Blunt, MS, NBC-HWC, by calling 480-425-8700 or schedule an appointment online.